Enlivex Therapeutics Ltd. (ENLV)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 26.71M |
| Enterprise value | 424.73k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.89 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.29 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.22 |
| 52-week change 3 | -47.79% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 4.5900 |
| 52-week low 3 | 1.1500 |
| 50-day moving average 3 | 2.5936 |
| 200-day moving average 3 | 2.3389 |
Share statistics
| Avg vol (3-month) 3 | 180.25k |
| Avg vol (10-day) 3 | 43.72k |
| Shares outstanding 5 | 18.81M |
| Implied shares outstanding 6 | 18.94M |
| Float 8 | 14.55M |
| % held by insiders 1 | 11.67% |
| % held by institutions 1 | 9.56% |
| Shares short (30 Apr 2024) 4 | 263.18k |
| Short ratio (30 Apr 2024) 4 | 0.74 |
| Short % of float (30 Apr 2024) 4 | 1.50% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.40% |
| Shares short (prior month 28 Mar 2024) 4 | 236.38k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 06 Mar 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:8 |
| Last split date 3 | 06 Mar 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -30.09% |
| Return on equity (ttm) | -66.88% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -24.32M |
| Net income avi to common (ttm) | -29.07M |
| Diluted EPS (ttm) | -1.5600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 27.32M |
| Total cash per share (mrq) | 1.47 |
| Total debt (mrq) | 1.03M |
| Total debt/equity (mrq) | 3.43% |
| Current ratio (mrq) | 5.57 |
| Book value per share (mrq) | 1.62 |
Cash flow statement
| Operating cash flow (ttm) | -23.52M |
| Levered free cash flow (ttm) | -17.77M |
© 2024 Yahoo. All rights reserved.